Citadel Advisors
HCAT icon

Citadel Advisors’s Health Catalyst HCAT Stock Holding History

Citadel Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
55,800
+1,500
+3% +$2.17K ﹤0.01% 12612
2026
Q1 		$69K Buy
+54,300
New +$102K ﹤0.01% 12259
2025
Q2 		– Sell
-5,800
Closed -$26.3K – 13527
2025
Q1 		$26.3K Buy
5,800
+5,000
+625% +$26.5K ﹤0.01% 12931
2024
Q4 		$5.66K Sell
800
-5,600
-88% -$44.6K ﹤0.01% 13846
2024
Q3 		$52.1K Buy
6,400
+4,600
+256% +$33.2K ﹤0.01% 11862
2024
Q2 		$11.5K Sell
1,800
-9,000
-83% -$57.8K ﹤0.01% 13031
2024
Q1 		$81.3K Buy
10,800
+10,100
+1,443% +$92.2K ﹤0.01% 11633
2023
Q4 		$6.48K Sell
700
-15,500
-96% -$127K ﹤0.01% 13347
2023
Q3 		$164K Buy
16,200
+9,300
+135% +$111K ﹤0.01% 10214
2023
Q2 		$86.3K Buy
6,900
+4,100
+146% +$48.8K ﹤0.01% 11145
2023
Q1 		$32.7K Sell
2,800
-1,000
-26% -$12.7K ﹤0.01% 12648
2022
Q4 		$40.4K Sell
3,800
-15,100
-80% -$146K ﹤0.01% 12409
2022
Q3 		$183K Buy
+18,900
New +$250K ﹤0.01% 10492
2022
Q1 		– Sell
-9,500
Closed -$376K – 13984
2021
Q4 		$376K Sell
9,500
-4,700
-33% -$214K ﹤0.01% 10388
2021
Q3 		$710K Buy
14,200
+3,300
+30% +$180K ﹤0.01% 9033
2021
Q2 		$605K Buy
+10,900
New +$581K ﹤0.01% 9600
2021
Q1 		– Sell
-12,600
Closed -$548K – 13385
2020
Q4 		$548K Sell
12,600
-18,900
-60% -$697K ﹤0.01% 7962
2020
Q3 		$1.15M Buy
+31,500
New +$1.07M ﹤0.01% 5772

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's HCAT Position: Q2 2026 in Review

Citadel Advisors opened a new position in Health Catalyst (HCAT) in Q2 2026: 453,214 shares worth $902K. The stake represents ﹤0.01% of the portfolio and ranks #8455 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in HCAT as recently as Q2 2025.

Citadel Advisors first reported a position in HCAT in Q3 2019 and has held it in 24 quarters since. The position peaked at $12.4M in Q1 2022. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Citadel Advisors held 453,214 shares of Health Catalyst worth $902K as of Q2 2026.
  • Health Catalyst was a new Citadel Advisors position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8455 holding.
  • Citadel Advisors first reported a position in Health Catalyst in Q3 2019 and has held it in 24 quarters since.
  • Citadel Advisors's Health Catalyst position peaked at $12.4M in Q1 2022.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.